Literature DB >> 11333892

Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.

M F Sprinzl1, H Oberwinkler, H Schaller, U Protzer.   

Abstract

For the study of hepatitis B virus infection, no permissive cell line or small animal is available. Stably transfected cell lines and transgenic mice which contain hepadnavirus genomes produce virus, but--unlike in natural infection--from an integrated viral transcription template. To transfer hepadnavirus genomes across the species barrier, we developed adenovirus vectors in which 1.3-fold-overlength human and duck hepatitis B virus genomes were inserted. The adenovirus-mediated genome transfer efficiently initiated hepadnavirus replication from an extrachromosomal template in established cell lines, in primary hepatocytes from various species, and in the livers of mice. Following the transfer, hepatitis B virus proteins, genomic RNA, and all replicative DNA intermediates were detected. Detection of covalently closed circular DNA in hepatoma cell lines and in primary hepatocytes indicated that an intracellular replication cycle independent from the transferred linear viral genome was established. High-titer hepatitis B virions were released into the culture medium of hepatoma cells and the various primary hepatocytes. In addition, infectious virions were secreted into the sera of mice. In conclusion, adenovirus-mediated genome transfer initiated efficient hepatitis B virus replication in cultured liver cells and in the experimental animals from an extrachromosomal template. This will allow development of small-animal systems of hepatitis B virus infection and will facilitate study of pathogenicity of wild-type and mutant viruses as well as of virus-host interaction and new therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11333892      PMCID: PMC114916          DOI: 10.1128/JVI.75.11.5108-5118.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  A splice hepadnavirus RNA that is essential for virus replication.

Authors:  S Obert; B Zachmann-Brand; E Deindl; W Tucker; R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

Review 2.  The treatment of chronic viral hepatitis.

Authors:  J H Hoofnagle; A M di Bisceglie
Journal:  N Engl J Med       Date:  1997-01-30       Impact factor: 91.245

3.  Evaluation of HBV promoters for use in hepatic gene therapy.

Authors:  P Löser; V Sandig; I Kirillova; M Strauss
Journal:  Biol Chem Hoppe Seyler       Date:  1996-03

4.  Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo.

Authors:  E Walter; R Keist; B Niederöst; I Pult; H E Blum
Journal:  Hepatology       Date:  1996-07       Impact factor: 17.425

Review 5.  Hepatitis B virus replication--an update.

Authors:  M Nassal; H Schaller
Journal:  J Viral Hepat       Date:  1996-09       Impact factor: 3.728

Review 6.  The woodchuck: an animal model for hepatitis B virus infection in man.

Authors:  M Roggendorf; T K Tolle
Journal:  Intervirology       Date:  1995       Impact factor: 1.763

7.  Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences.

Authors:  E Mandart; A Kay; F Galibert
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  Hepatitis B virus genes and their expression in E. coli.

Authors:  M Pasek; T Goto; W Gilbert; B Zink; H Schaller; P MacKay; G Leadbetter; K Murray
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

9.  Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus.

Authors:  R Q Yan; J J Su; D R Huang; Y C Gan; C Yang; G H Huang
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

10.  Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.

Authors:  C Niederau; T Heintges; S Lange; G Goldmann; C M Niederau; L Mohr; D Häussinger
Journal:  N Engl J Med       Date:  1996-05-30       Impact factor: 91.245

View more
  53 in total

1.  Hepatocytes traffic and export hepatitis B virus basolaterally by polarity-dependent mechanisms.

Authors:  Purnima Bhat; Michelle J Snooks; David A Anderson
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance.

Authors:  Maria Papatriantafyllou; Gerhard Moldenhauer; Julia Ludwig; Anna Tafuri; Natalio Garbi; Gorana Hollmann; Günter Küblbeck; Alexandra Klevenz; Sabine Schmitt; Georg Pougialis; Christof Niehrs; Hermann-Josef Gröne; Gunter J Hämmerling; Bernd Arnold; Thilo Oelert
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

3.  Inhibition of cellular proteasome activities mediates HBX-independent hepatitis B virus replication in vivo.

Authors:  Zhensheng Zhang; Eun Sun; Jing-hsiung James Ou; T Jake Liang
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

4.  Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.

Authors:  Yuchen Xia; Arnaud Carpentier; Xiaoming Cheng; Peter Daniel Block; Yao Zhao; Zhensheng Zhang; Ulrike Protzer; T Jake Liang
Journal:  J Hepatol       Date:  2016-10-14       Impact factor: 25.083

5.  Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance.

Authors:  Béatrice Bailly-Maitre; Bengt F Belgardt; Sabine D Jordan; Beatrice Coornaert; Miriam John von Freyend; Andre Kleinridders; Jan Mauer; Michael Cuddy; Christina L Kress; Diana Willmes; Manuela Essig; Brigitte Hampel; Ulrike Protzer; John C Reed; Jens C Brüning
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

6.  Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.

Authors:  Yuchen Xia; Xiaoming Cheng; Yao Li; Kristin Valdez; Weiping Chen; T Jake Liang
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

7.  Anti-HBV activity of TRL mediated by recombinant adenovirus.

Authors:  Wei-Dong Gong; Ya Zhao; Jun Yi; Jin Ding; Jun Liu; Cai-Fang Xue
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

8.  Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice.

Authors:  Zhihua Qi; Gaiyun Li; Hao Hu; Chunhui Yang; Xiaoming Zhang; Qibin Leng; Youhua Xie; Demin Yu; Xinxin Zhang; Yueqiu Gao; Ke Lan; Qiang Deng
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

9.  Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner.

Authors:  Zhensheng Zhang; Ulrike Protzer; Zongyi Hu; James Jacob; T Jake Liang
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential.

Authors:  Amy J Clippinger; Michael J Bouchard
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.